Beta Thalassemia Market Set to Witness Significant Expansion by 2034 | DelveInsight Report
Leading companies such as Novartis, Merck, and Bristol Myers Squibb are driving advancements in Beta Thalassemia treatments to enhance patient care. LAS VEGAS , NV, UNITED STATES, February 4, 2025 /EINPresswire.com/ -- DelveInsight’s “Beta …